Last week , our colleagues Marta Rayo and Marta Morales participated in the nTRACK 30 MM follow up meeting to discuss the project progress with all the partners.

The H2020 nTRACK project has the objective to develop nano-imaging reagents for stem cell tracking and biodistribution.

This time, and due to the current situation, the meeting was celebrated in a digital way with all partners virtually connected thanks to the organization by the Coordinator Leitat.


About nTRACK:

The main goal of nTrack is to develop a safe and highly sensitive multimodal nano-imaging agent enabling non-invasive, quantitative and longitudinal stem cell tracking and whole body biodistribution using the combination of positron emission tomography-computed tomography (PET-CT) and positron emission tomography-magnetic resonance imaging (PET-MRI), which are both structural and functional imaging modalities that are clinically available. A second goal of nTrack is to establish a predictive model for early assessment of treatment effectiveness for muscle regeneration, based on short-term evaluation of the typical migration and biodistribution patterns of stem cells.

You can follow the project and check for more information on its website: http://www.n-track.eu/

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 761031. This publicationreflects only the author’s views and the European Union is not liable for any use that may be made of the information contained therein.
Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

La exposición al frío y al calor duran...

El equipo de investigadores observó cambios en el...

Uso de RNA móviles para mejorar la asim...

El gen AtCDF3 promueve una mayor producción de az...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Destacadas

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

En nuestro post hablamos sobre este interesante tipo de célula del si...

Ysios Capital invierte en Memo Therapeut...

by Ysios Capital

Ysios Capital, gestora española líder en inversiones en el sector bi...

Diapositiva de Fotos